외부 비강 확장기 시장 : 용도별, 최종사용자별, 유통 채널별 - 세계 기회 분석과 산업 예측(2024-2033년)

External Nasal Dilator Market By Application (Snoring, Sleep apnea, Nasal congestion, Others) , By End User (Adults, Pediatric) By Distribution Channel (Offline, Online) : Global Opportunity Analysis and Industry Forecast, 2024-2033

US $ 4,425 ￦ 6,062,000

PDF (Business License)

PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄는 5회 가능하며, 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다. 2명 이상이 이용할 경우, 추가 요금을 지불하여 라이선스 업그레이드로 최대 5명까지 이용 가능합니다.

US $ 7,412 ￦ 10,155,000

PDF (Enterprise User License) & Excel (Data Pack) & Free Update

PDF 보고서 및 Excel 데이터를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다. 보고서 업데이트 서비스가 무료로 제공됩니다.

한글목차

세계의 외부 비강 확장기 시장은 2023년에 9,830만 달러로 평가되며, 2024-2033년 CAGR 5.1%로 성장하며, 2033년에는 1억 6,240만 달러에 달할 것으로 예측됩니다.

외부 비강 확장기는 비강을 외부에서 부드럽게 열어 비강의 공기 흐름을 증가시키기 위해 고안된 혁신적인 장비입니다. 이 장비는 수면 무호흡증, 코 막힘, 코골이 또는 운동 중 호흡을 개선하려는 사람들에게 특히 유용합니다. 외부 비강 확장기는 호흡과 전반적인 건강을 개선하기 위해 공기 흐름의 제약을 완화하도록 설계되었습니다.

외부 비강 확장기 세계 시장 성장은 수면 무호흡증 유병률의 급증, 코 막힘, 코골이 또는 운동 중 호흡을 개선하려는 사람들을 위한 외부 비강 확장기의 인기와 채택 증가와 같은 몇 가지 요인에 의해 주도되고 있습니다. 또한 알레르기, 감기, 부비동염 및 해부학적 이상은 코 막힘의 주요 원인입니다. 따라서 비강 확장기는 비강 통로를 확장하여 코 막힘을 제거하고 더 나은 공기 흐름과 호흡을 촉진하는 비 침습적 방법을 설명합니다. 또한 호흡 패턴, 수면의 질 및 기타 측정 기준을 모니터링하기 위해 특정 외부 비강 확장기는 웨어러블 건강 기술 증가 추세에 따라 센서 또는 네트워크 요소를 통합합니다. 따라서 최종사용자는 이 데이터를 통해 전체 호흡기 건강 상태와 코의 공기 흐름에 대해 더 많은 정보를 얻을 수 있습니다.

그러나 이러한 확장기의 비용과 접근성이 시장 성장을 저해하고 있습니다. 반면, 기술 발전, 수면 무호흡증 및 코골이 유병률 증가는 외부 비강 확장기 시장의 기회를 촉진할 것으로 예상됩니다. 예를 들어 세계 의료기기 제조업체인 Rhinomed는 코를 통한 약물 투여, 수면의 질, 상기도 질환 진단 및 호흡을 개선하는 MuteTM는 코를 통한 공기 흐름을 평균 38% 증가시켜 코골이의 빈도와 강도를 줄이고 아침의 상쾌함을 모두 향상시킬 수 있습니다. 사용자 실험에 따르면 코골이 환자는 파트너의 수면의 질과 자신의 호흡의 질을 모두 향상시키고 있다는 사실을 알고 안심하고 잠을 잘 수 있습니다.

세분화 개요

외부 비강 확장기 시장은 용도, 최종사용자, 유통 채널 및 지역으로 분류됩니다. 용도에 따라 시장은 코골이, 수면무호흡증, 코막힘, 기타로 나뉩니다. 최종사용자에 따라 성인과 소아로 나뉩니다. 유통 채널에 따라 온라인 채널과 오프라인 채널로 분류됩니다. 지역별로는 북미, 유럽, 아시아태평양, 라틴아메리카, 중동 및 아프리카로 분석됩니다.

경쟁사 분석

이 보고서는 맞춤 제작이 가능합니다(별도의 비용과 기간이 소요되므로 자세한 내용은 영업 담당자에게 문의하시기 바랍니다).

• 국가, 지역 및 세계 수준의 환자/역학 데이터
• 규제 가이드라인
• 고객의 관심사에 따른 추가 기업 개요
• 국가별 또는 지역별 추가 분석 - 시장 규모 및 전망
• 기업 개요 확대 리스트
• 과거 시장 데이터
• SWOT 분석

목차

제1장 서론

제2장 개요

제3장 시장 구도

• 시장의 정의와 범위
• 주요 조사 결과
  • 주요 투자 기회
  • 주요 성공 전략
• Porter's Five Forces 분석
• 시장 역학
  • 촉진요인
  • 억제요인
  • 기회

제4장 외부 비강 확장기 시장 : 용도별

• 시장 개요
• 코골이
• 수면무호흡증
• 코막힘
• 기타

제5장 외부 비강 확장기 시장 : 최종사용자별

• 시장 개요
• 성인
• 소아

제6장 외부 비강 확장기 시장 : 유통 채널별

• 시장 개요
• 오프라인
• 온라인

제7장 외부 비강 확장기 시장 : 지역별

• 시장 개요
• 북미
  • 주요 시장 동향과 기회
  • 미국의 외부 비강 확장기 시장
  • 캐나다의 외부 비강 확장기 시장
  • 멕시코의 외부 비강 확장기 시장
• 유럽
  • 주요 시장 동향과 기회
  • 프랑스의 외부 비강 확장기 시장
  • 독일의 외부 비강 확장기 시장
  • 이탈리아의 외부 비강 확장기 시장
  • 스페인의 외부 비강 확장기 시장
  • 영국의 외부 비강 확장기 시장
  • 기타 유럽의 외부 비강 확장기 시장
• 아시아태평양
  • 주요 시장 동향과 기회
  • 중국의 외부 비강 확장기 시장
  • 일본의 외부 비강 확장기 시장
  • 인도의 외부 비강 확장기 시장
  • 한국의 외부 비강 확장기 시장
  • 호주의 외부 비강 확장기 시장
  • 기타 아시아태평양의 외부 비강 확장기 시장
• 라틴아메리카·중동 및 아프리카
  • 주요 시장 동향과 기회
  • 브라질의 외부 비강 확장기 시장
  • 남아프리카공화국의 외부 비강 확장기 시장
  • 사우디아라비아의 외부 비강 확장기 시장
  • 기타 라틴아메리카·중동 및 아프리카의 외부 비강 확장기 시장

제8장 경쟁 구도

• 서론
• 주요 성공 전략
• 주요 10 기업의 제품 지도제작
• 경쟁 대시보드
• 경쟁 히트맵
• 주요 기업의 포지셔닝(2023년)

제9장 기업 개요

• GlaxoSmithKline Plc
• HealthRight Products LLC
• Zhongshan Hongze Medical Technology Co., Ltd.
• Permira I.P Limited
• Health Right Products LLC
• AirWare Labs
• Splintek Inc
• Scandinavian Formulas
• Tomed GmbH
• Rhinomed Limited

KSA

영문 목차

영문목차

The global external nasal dilator market was valued at $98.3 million in 2023, and is projected to reach $162.4 million by 2033, growing at a CAGR of 5.1% from 2024 to 2033.

An external nasal dilator is an innovative device designed to enhance the nasal airflow by gently opening the nasal passages from the outside. This device is especially beneficial for people who have sleep apnea, nasal congestion, snoring, or who want to breathe better when exercising. An external nasal dilator is designed to alleviate airflow constraints to improve breathing and general health.

The growth of the global external nasal dilator market is driven by several factors such as surge in the prevalence of sleep apnea, increasing popularity and adoption of external nasal dilators for, nasal congestion, snoring, or who want to breathe better when exercising. In addition, allergies, colds, sinusitis, and anatomical anomalies are major causes of nasal congestion. Thus, by enlarging the nasal passageways, external nasal dilators provide a non-invasive way to relieve nasal congestion and facilitate better airflow and breathing. Furthermore, to monitor breathing patterns, sleep quality, and other metrics, certain external nasal dilators are incorporating sensors or networking elements in line with the growing trend of wearable health technology. Thus, end users can learn more about their overall respiratory health and nasal airflow from this data.

However, cost and accessibility of these dilators hinder the growth of the market. On the other hand, technological advancements, increasing prevalence of sleep apnea, snoring is expected to drive the external nasal dilator market opportunity. For instance, the global medical device manufacturer Rhinomed improves nasal medication administration, sleep quality, upper respiratory disease diagnostics, and respiration. By increasing airflow through the nose by 38% on average, MuteTM can lessen the frequency and intensity of snoring and improve both of your morning feelings of refreshment. According to user trials, snorers can sleep easily knowing that they're enhancing both the quality of their partner's sleep and their own breathing.

Segmentation Overview

The external nasal dilator market is segmented into application, end user, distribution channel, and region. Depending on the application, the market is divided into snoring, sleep apnea, nasal congestion, and others. As per end user, it is bifurcated into adults and pediatric. According to distribution channel, the market is classified into online channel and offline channel. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Competitive Analysis

The major players operating in the external nasal dilator industry include GlaxoSmithKline Plc, HealthRight Products LLC, and Zhongshan Hongze Medical Technology Co., Ltd. Other players in the market are Permira I.P Limited, Health Right Products LLC, AirWare Labs., ?Splintek Inc, Scandinavian Formulas, Tomed GmbH, Creganna, Nasilator, Hubei YJT Technology Co., Ltd, Rhinomed Limited, Nasilator, Nasanita, ?SHREYAAS HEALTH CARE PVT LTD., and Walgreen Co. These companies have been active in adopting different tactics to maintain their position in the competitive market.

Additional benefits you will get with this purchase are:

• Quarterly Update and* (only available with a corporate license, on listed price)
• 5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
• Free Upcoming Version on the Purchase of Five and Enterprise User License.
• 16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
• 15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
• Free data Pack on the Five and Enterprise User License. (Excel version of the report)
• Free Updated report if the report is 6-12 months old or older.
• 24-hour priority response*
• Free Industry updates and white papers.

Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)

• Patient/epidemiology data at country, region, global level
• Regulatory Guidelines
• Additional company profiles with specific to client's interest
• Additional country or region analysis- market size and forecast
• Expanded list for Company Profiles
• Historic market data
• SWOT Analysis

Key Market Segments

By Application

• Snoring
• Sleep apnea
• Nasal congestion
• Others

By End User

• Adults
• Pediatric

By Distribution Channel

• Offline
• Online

By Region

• North America
  • U.S.
  • Canada
  • Mexico
• Europe
  • France
  • Germany
  • Italy
  • Spain
  • UK
  • Rest of Europe
• Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Rest of Asia-Pacific
• LAMEA
  • Brazil
  • South Africa
  • Saudi Arabia
  • Rest of LAMEA

Key Market Players:

• GlaxoSmithKline Plc
• HealthRight Products LLC
• Zhongshan Hongze Medical Technology Co., Ltd.
• Permira I.P Limited
• Health Right Products LLC
• AirWare Labs
• Splintek Inc
• Scandinavian Formulas
• Tomed GmbH
• Rhinomed Limited

TABLE OF CONTENTS

CHAPTER 1: INTRODUCTION

• 1.1. Report Description
• 1.2. Key Market Segments
• 1.3. Key Benefits
• 1.4. Research Methodology
  • 1.4.1. Primary Research
  • 1.4.2. Secondary Research
  • 1.4.3. Analyst Tools and Models

CHAPTER 2: EXECUTIVE SUMMARY

• 2.1. CXO Perspective

CHAPTER 3: MARKET LANDSCAPE

• 3.1. Market Definition and Scope
• 3.2. Key Findings
  • 3.2.1. Top Investment Pockets
  • 3.2.2. Top Winning Strategies
• 3.3. Porter's Five Forces Analysis
  • 3.3.1. Bargaining Power of Suppliers
  • 3.3.2. Threat of New Entrants
  • 3.3.3. Threat of Substitutes
  • 3.3.4. Competitive Rivalry
  • 3.3.5. Bargaining Power among Buyers
• 3.4. Market Dynamics
  • 3.4.1. Drivers
  • 3.4.2. Restraints
  • 3.4.3. Opportunities

CHAPTER 4: EXTERNAL NASAL DILATOR MARKET, BY APPLICATION

• 4.1. Market Overview
  • 4.1.1 Market Size and Forecast, By Application
• 4.2. Snoring
  • 4.2.1. Key Market Trends, Growth Factors and Opportunities
  • 4.2.2. Market Size and Forecast, By Region
  • 4.2.3. Market Share Analysis, By Country
• 4.3. Sleep Apnea
  • 4.3.1. Key Market Trends, Growth Factors and Opportunities
  • 4.3.2. Market Size and Forecast, By Region
  • 4.3.3. Market Share Analysis, By Country
• 4.4. Nasal Congestion
  • 4.4.1. Key Market Trends, Growth Factors and Opportunities
  • 4.4.2. Market Size and Forecast, By Region
  • 4.4.3. Market Share Analysis, By Country
• 4.5. Others
  • 4.5.1. Key Market Trends, Growth Factors and Opportunities
  • 4.5.2. Market Size and Forecast, By Region
  • 4.5.3. Market Share Analysis, By Country

CHAPTER 5: EXTERNAL NASAL DILATOR MARKET, BY END USER

• 5.1. Market Overview
  • 5.1.1 Market Size and Forecast, By End User
• 5.2. Adults
  • 5.2.1. Key Market Trends, Growth Factors and Opportunities
  • 5.2.2. Market Size and Forecast, By Region
  • 5.2.3. Market Share Analysis, By Country
• 5.3. Pediatric
  • 5.3.1. Key Market Trends, Growth Factors and Opportunities
  • 5.3.2. Market Size and Forecast, By Region
  • 5.3.3. Market Share Analysis, By Country

CHAPTER 6: EXTERNAL NASAL DILATOR MARKET, BY DISTRIBUTION CHANNEL

• 6.1. Market Overview
  • 6.1.1 Market Size and Forecast, By Distribution Channel
• 6.2. offline
  • 6.2.1. Key Market Trends, Growth Factors and Opportunities
  • 6.2.2. Market Size and Forecast, By Region
  • 6.2.3. Market Share Analysis, By Country
• 6.3. Online
  • 6.3.1. Key Market Trends, Growth Factors and Opportunities
  • 6.3.2. Market Size and Forecast, By Region
  • 6.3.3. Market Share Analysis, By Country

CHAPTER 7: EXTERNAL NASAL DILATOR MARKET, BY REGION

• 7.1. Market Overview
  • 7.1.1 Market Size and Forecast, By Region
• 7.2. North America
  • 7.2.1. Key Market Trends and Opportunities
  • 7.2.2. Market Size and Forecast, By Application
  • 7.2.3. Market Size and Forecast, By End User
  • 7.2.4. Market Size and Forecast, By Distribution Channel
  • 7.2.5. Market Size and Forecast, By Country
  • 7.2.6. U.S. External Nasal Dilator Market
    • 7.2.6.1. Market Size and Forecast, By Application
    • 7.2.6.2. Market Size and Forecast, By End User
    • 7.2.6.3. Market Size and Forecast, By Distribution Channel
  • 7.2.7. Canada External Nasal Dilator Market
    • 7.2.7.1. Market Size and Forecast, By Application
    • 7.2.7.2. Market Size and Forecast, By End User
    • 7.2.7.3. Market Size and Forecast, By Distribution Channel
  • 7.2.8. Mexico External Nasal Dilator Market
    • 7.2.8.1. Market Size and Forecast, By Application
    • 7.2.8.2. Market Size and Forecast, By End User
    • 7.2.8.3. Market Size and Forecast, By Distribution Channel
• 7.3. Europe
  • 7.3.1. Key Market Trends and Opportunities
  • 7.3.2. Market Size and Forecast, By Application
  • 7.3.3. Market Size and Forecast, By End User
  • 7.3.4. Market Size and Forecast, By Distribution Channel
  • 7.3.5. Market Size and Forecast, By Country
  • 7.3.6. France External Nasal Dilator Market
    • 7.3.6.1. Market Size and Forecast, By Application
    • 7.3.6.2. Market Size and Forecast, By End User
    • 7.3.6.3. Market Size and Forecast, By Distribution Channel
  • 7.3.7. Germany External Nasal Dilator Market
    • 7.3.7.1. Market Size and Forecast, By Application
    • 7.3.7.2. Market Size and Forecast, By End User
    • 7.3.7.3. Market Size and Forecast, By Distribution Channel
  • 7.3.8. Italy External Nasal Dilator Market
    • 7.3.8.1. Market Size and Forecast, By Application
    • 7.3.8.2. Market Size and Forecast, By End User
    • 7.3.8.3. Market Size and Forecast, By Distribution Channel
  • 7.3.9. Spain External Nasal Dilator Market
    • 7.3.9.1. Market Size and Forecast, By Application
    • 7.3.9.2. Market Size and Forecast, By End User
    • 7.3.9.3. Market Size and Forecast, By Distribution Channel
  • 7.3.10. UK External Nasal Dilator Market
    • 7.3.10.1. Market Size and Forecast, By Application
    • 7.3.10.2. Market Size and Forecast, By End User
    • 7.3.10.3. Market Size and Forecast, By Distribution Channel
  • 7.3.11. Rest of Europe External Nasal Dilator Market
    • 7.3.11.1. Market Size and Forecast, By Application
    • 7.3.11.2. Market Size and Forecast, By End User
    • 7.3.11.3. Market Size and Forecast, By Distribution Channel
• 7.4. Asia-Pacific
  • 7.4.1. Key Market Trends and Opportunities
  • 7.4.2. Market Size and Forecast, By Application
  • 7.4.3. Market Size and Forecast, By End User
  • 7.4.4. Market Size and Forecast, By Distribution Channel
  • 7.4.5. Market Size and Forecast, By Country
  • 7.4.6. China External Nasal Dilator Market
    • 7.4.6.1. Market Size and Forecast, By Application
    • 7.4.6.2. Market Size and Forecast, By End User
    • 7.4.6.3. Market Size and Forecast, By Distribution Channel
  • 7.4.7. Japan External Nasal Dilator Market
    • 7.4.7.1. Market Size and Forecast, By Application
    • 7.4.7.2. Market Size and Forecast, By End User
    • 7.4.7.3. Market Size and Forecast, By Distribution Channel
  • 7.4.8. India External Nasal Dilator Market
    • 7.4.8.1. Market Size and Forecast, By Application
    • 7.4.8.2. Market Size and Forecast, By End User
    • 7.4.8.3. Market Size and Forecast, By Distribution Channel
  • 7.4.9. South Korea External Nasal Dilator Market
    • 7.4.9.1. Market Size and Forecast, By Application
    • 7.4.9.2. Market Size and Forecast, By End User
    • 7.4.9.3. Market Size and Forecast, By Distribution Channel
  • 7.4.10. Australia External Nasal Dilator Market
    • 7.4.10.1. Market Size and Forecast, By Application
    • 7.4.10.2. Market Size and Forecast, By End User
    • 7.4.10.3. Market Size and Forecast, By Distribution Channel
  • 7.4.11. Rest of Asia-Pacific External Nasal Dilator Market
    • 7.4.11.1. Market Size and Forecast, By Application
    • 7.4.11.2. Market Size and Forecast, By End User
    • 7.4.11.3. Market Size and Forecast, By Distribution Channel
• 7.5. LAMEA
  • 7.5.1. Key Market Trends and Opportunities
  • 7.5.2. Market Size and Forecast, By Application
  • 7.5.3. Market Size and Forecast, By End User
  • 7.5.4. Market Size and Forecast, By Distribution Channel
  • 7.5.5. Market Size and Forecast, By Country
  • 7.5.6. Brazil External Nasal Dilator Market
    • 7.5.6.1. Market Size and Forecast, By Application
    • 7.5.6.2. Market Size and Forecast, By End User
    • 7.5.6.3. Market Size and Forecast, By Distribution Channel
  • 7.5.7. South Africa External Nasal Dilator Market
    • 7.5.7.1. Market Size and Forecast, By Application
    • 7.5.7.2. Market Size and Forecast, By End User
    • 7.5.7.3. Market Size and Forecast, By Distribution Channel
  • 7.5.8. Saudi Arabia External Nasal Dilator Market
    • 7.5.8.1. Market Size and Forecast, By Application
    • 7.5.8.2. Market Size and Forecast, By End User
    • 7.5.8.3. Market Size and Forecast, By Distribution Channel
  • 7.5.9. Rest of LAMEA External Nasal Dilator Market
    • 7.5.9.1. Market Size and Forecast, By Application
    • 7.5.9.2. Market Size and Forecast, By End User
    • 7.5.9.3. Market Size and Forecast, By Distribution Channel

CHAPTER 8: COMPETITIVE LANDSCAPE

• 8.1. Introduction
• 8.2. Top Winning Strategies
• 8.3. Product Mapping of Top 10 Player
• 8.4. Competitive Dashboard
• 8.5. Competitive Heatmap
• 8.6. Top Player Positioning, 2023

CHAPTER 9: COMPANY PROFILES

• 9.1. GlaxoSmithKline Plc
  • 9.1.1. Company Overview
  • 9.1.2. Key Executives
  • 9.1.3. Company Snapshot
  • 9.1.4. Operating Business Segments
  • 9.1.5. Product Portfolio
  • 9.1.6. Business Performance
  • 9.1.7. Key Strategic Moves and Developments
• 9.2. HealthRight Products LLC
  • 9.2.1. Company Overview
  • 9.2.2. Key Executives
  • 9.2.3. Company Snapshot
  • 9.2.4. Operating Business Segments
  • 9.2.5. Product Portfolio
  • 9.2.6. Business Performance
  • 9.2.7. Key Strategic Moves and Developments
• 9.3. Zhongshan Hongze Medical Technology Co., Ltd.
  • 9.3.1. Company Overview
  • 9.3.2. Key Executives
  • 9.3.3. Company Snapshot
  • 9.3.4. Operating Business Segments
  • 9.3.5. Product Portfolio
  • 9.3.6. Business Performance
  • 9.3.7. Key Strategic Moves and Developments
• 9.4. Permira I.P Limited
  • 9.4.1. Company Overview
  • 9.4.2. Key Executives
  • 9.4.3. Company Snapshot
  • 9.4.4. Operating Business Segments
  • 9.4.5. Product Portfolio
  • 9.4.6. Business Performance
  • 9.4.7. Key Strategic Moves and Developments
• 9.5. Health Right Products LLC
  • 9.5.1. Company Overview
  • 9.5.2. Key Executives
  • 9.5.3. Company Snapshot
  • 9.5.4. Operating Business Segments
  • 9.5.5. Product Portfolio
  • 9.5.6. Business Performance
  • 9.5.7. Key Strategic Moves and Developments
• 9.6. AirWare Labs
  • 9.6.1. Company Overview
  • 9.6.2. Key Executives
  • 9.6.3. Company Snapshot
  • 9.6.4. Operating Business Segments
  • 9.6.5. Product Portfolio
  • 9.6.6. Business Performance
  • 9.6.7. Key Strategic Moves and Developments
• 9.7. Splintek Inc
  • 9.7.1. Company Overview
  • 9.7.2. Key Executives
  • 9.7.3. Company Snapshot
  • 9.7.4. Operating Business Segments
  • 9.7.5. Product Portfolio
  • 9.7.6. Business Performance
  • 9.7.7. Key Strategic Moves and Developments
• 9.8. Scandinavian Formulas
  • 9.8.1. Company Overview
  • 9.8.2. Key Executives
  • 9.8.3. Company Snapshot
  • 9.8.4. Operating Business Segments
  • 9.8.5. Product Portfolio
  • 9.8.6. Business Performance
  • 9.8.7. Key Strategic Moves and Developments
• 9.9. Tomed GmbH
  • 9.9.1. Company Overview
  • 9.9.2. Key Executives
  • 9.9.3. Company Snapshot
  • 9.9.4. Operating Business Segments
  • 9.9.5. Product Portfolio
  • 9.9.6. Business Performance
  • 9.9.7. Key Strategic Moves and Developments
• 9.10. Rhinomed Limited
  • 9.10.1. Company Overview
  • 9.10.2. Key Executives
  • 9.10.3. Company Snapshot
  • 9.10.4. Operating Business Segments
  • 9.10.5. Product Portfolio
  • 9.10.6. Business Performance
  • 9.10.7. Key Strategic Moves and Developments

관련자료